BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chi FL, Gu FM, Dai CF, Chen B, Li HW. Survival outcomes in surgical treatment of 72 cases of squamous cell carcinoma of the temporal bone. Otol Neurotol 2011;32:665-9. [PMID: 21436754 DOI: 10.1097/MAO.0b013e318210b90f] [Cited by in Crossref: 45] [Cited by in F6Publishing: 15] [Article Influence: 4.1] [Reference Citation Analysis]
Number Citing Articles
1 Shen W, Sakamoto N, Yang L. Prognostic models to predict overall and cause-specific survival for patients with middle ear cancer: a population-based analysis. BMC Cancer 2014;14:554. [PMID: 25081186 DOI: 10.1186/1471-2407-14-554] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
2 Nabuurs CH, Kievit W, Labbé N, Leemans CR, Smit CFGM, van den Brekel MWM, Pauw RJ, van der Laan BFAM, Jansen JC, Lacko M, Braunius WW, Morita S, Wierzbicka M, Matoba T, Hanai N, Takes RP, Kunst HPM. Evaluation of the modified Pittsburgh classification for predicting the disease-free survival outcome of squamous cell carcinoma of the external auditory canal. Head Neck 2020;42:3609-22. [PMID: 32794253 DOI: 10.1002/hed.26424] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
3 Iwami K, Watanabe T, Osuka K, Ogawa T, Miyachi S, Fujimoto Y. Combined Exoscopic and Endoscopic Technique for Craniofacial Resection. Curr Oncol 2021;28:3945-58. [PMID: 34677254 DOI: 10.3390/curroncol28050336] [Reference Citation Analysis]
4 Morris LG, Mehra S, Shah JP, Bilsky MH, Selesnick SH, Kraus DH. Predictors of survival and recurrence after temporal bone resection for cancer. Head Neck 2012;34:1231-9. [PMID: 21953902 DOI: 10.1002/hed.21883] [Cited by in Crossref: 61] [Cited by in F6Publishing: 49] [Article Influence: 5.5] [Reference Citation Analysis]
5 Lechner M, Sutton L, Murkin C, Masterson L, O'Flynn P, Wareing MJ, Tatla T, Saeed S. Squamous cell cancer of the temporal bone: a review of the literature. Eur Arch Otorhinolaryngol 2021;278:2225-8. [PMID: 32869160 DOI: 10.1007/s00405-020-06281-4] [Reference Citation Analysis]
6 Basura GJ, Smith JD, Ellsperman S, Bhangale A, Brenner JC. Targeted molecular characterization of external auditory canal squamous cell carcinomas. Laryngoscope Investig Otolaryngol 2021;6:1151-7. [PMID: 34667860 DOI: 10.1002/lio2.654] [Reference Citation Analysis]
7 Lovin BD, Gidley PW. Squamous cell carcinoma of the temporal bone: A current review. Laryngoscope Investig Otolaryngol. 2019;4:684-692. [PMID: 31890889 DOI: 10.1002/lio2.330] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 5.7] [Reference Citation Analysis]
8 Wierzbicka M, Niemczyk K, Bruzgielewicz A, Durko M, Klatka J, Kopeć T, Osuch-Wójcikiewicz E, Pietruszewska W, Szymański M, Szyfter W. Multicenter experiences in temporal bone cancer surgery based on 89 cases. PLoS One 2017;12:e0169399. [PMID: 28225795 DOI: 10.1371/journal.pone.0169399] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
9 Pandiar D, Aravind S, Nayanar SK, Babu S. Incipient Warthin tumor of intraparotid lymph node in a patient with squamous cell carcinoma of the external auditory canal: An incidental finding. Natl J Maxillofac Surg 2020;11:113-6. [PMID: 33041588 DOI: 10.4103/njms.NJMS_46_18] [Reference Citation Analysis]
10 Essig GF, Kitipornchai L, Adams F, Zarate D, Gandhi M, Porceddu S, Panizza B. Lateral temporal bone resection in advanced cutaneous squamous cell carcinoma: report of 35 patients. J Neurol Surg B Skull Base 2013;74:54-9. [PMID: 24436889 DOI: 10.1055/s-0032-1331021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
11 Zhang T, Dai C, Wang Z. The misdiagnosis of external auditory canal carcinoma. Eur Arch Otorhinolaryngol 2013;270:1607-13. [PMID: 22926989 DOI: 10.1007/s00405-012-2159-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
12 Saijo K, Ueki Y, Tanaka R, Yokoyama Y, Omata J, Takahashi T, Ota H, Shodo R, Yamazaki K, Togashi T, Okabe R, Matsuyama H, Honda K, Sato Y, Morita Y, Takahashi K, Horii A. Treatment Outcome of External Auditory Canal Carcinoma: The Utility of Lateral Temporal Bone Resection. Front Surg 2021;8:708245. [PMID: 34527695 DOI: 10.3389/fsurg.2021.708245] [Reference Citation Analysis]
13 Kitani Y, Kubota A, Furukawa M, Sato K, Nakayama Y, Nonaka T, Mizoguchi N. Primary definitive radiotherapy with or without chemotherapy for squamous cell carcinoma of the temporal bone. Eur Arch Otorhinolaryngol 2016;273:1293-8. [PMID: 25822291 DOI: 10.1007/s00405-015-3616-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
14 Seligman KL, Sun DQ, Ten Eyck PP, Schularick NM, Hansen MR. Temporal bone carcinoma: Treatment patterns and survival. Laryngoscope 2020;130:E11-20. [PMID: 30874314 DOI: 10.1002/lary.27877] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
15 Iwami K, Fujii M, Nishio N, Maruo T, Fujimoto Y, Takanari K, Kamei Y, Yamada M, Ogawa T, Osuka K, Saito K. Skull Base Invasion Patterns of Malignant Head and Neck Tumors: A Neurosurgical Perspective. J Neurol Surg B Skull Base 2021;82:e120-30. [PMID: 34306927 DOI: 10.1055/s-0039-3402034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 García-Marín R, Cabal VN, Fernández-Cedrón Bermejo C, Riobello C, Suárez-Fernández L, Codina-Martínez H, Navarro-García A, Lorenzo-Guerra SL, García-Martínez J, Vivanco B, López F, Llorente JL, Hermsen MA. A Novel External Auditory Canal Squamous Cell Carcinoma Cell Line Sensitive to CDK4/6 Inhibition. Otolaryngol Head Neck Surg 2022;:1945998221089186. [PMID: 35349366 DOI: 10.1177/01945998221089186] [Reference Citation Analysis]
17 Wei L, Wang L, Liu Z, Wang M, Lu W, Zhao D, Yang B, Kong X, Ding Y, Wang Z. Dramatic response of CTNNB1 and VEGFR-2 mutant temporal bone squamous cell carcinoma to bevacizumab in combination with pemetrexed. Oncotarget 2017;8:57898-904. [PMID: 28915721 DOI: 10.18632/oncotarget.19649] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
18 Liu H, Dai C, Wu Q, Liu H, Li F. Expression profiling of long noncoding RNA identifies lnc-MMP3-1 as a prognostic biomarker in external auditory canal squamous cell carcinoma. Cancer Med 2017;6:2541-51. [PMID: 28960885 DOI: 10.1002/cam4.1213] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]